Gastrointestinal Endoscopy Unit, Humanitas Mater Domini, Varese, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Dig Endosc. 2024 Mar;36(3):351-358. doi: 10.1111/den.14606. Epub 2023 Jul 3.
Endoscopic retrograde cholangiopancreatography (ERCP) represents the gold standard for jaundice palliation in patients with distal malignant biliary obstruction (DMBO). Biliary drainage using electrocautery lumen apposing metal stent (EC-LAMS) is currently a well-established procedure when ERCP fails. In a palliative setting the endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) could represent an easy and valid option. We performed a prospective study with a new EC-LAMS with the primary aim to assess the clinical success rate of EUS-GBD as a first-line approach to the palliation of DMBO.
In all, 37 consecutive patients undergoing EUS-GBD with a new EC-LAMS were prospectively enrolled. Clinical success was defined as bilirubin level decrease >15% within 24 h and >50% within 14 days after EC-LAMS placement.
The mean age was 73.5 ± 10.8 years; there were 17 male patients (45.9%). EC-LAMS placement was technically feasible in all patients (100%) and the clinical success rate was 100%. Four patients (10.8%) experienced adverse events, one bleeding, one food impaction, and two cystic duct obstructions because of disease progression. No stent-related deaths were observed. The mean hospitalization was 7.7 ± 3.4 days. Median overall survival was 4 months (95% confidence interval 1-8).
Endoscopic ultrasound-guided gallbladder drainage with the new EC-LAMS is a valid option in palliative endoscopic biliary drainage as a first-step approach in low survival patients with malignant jaundice unfit for surgery. A smaller diameter EC-LAMS should be preferred, particularly if the drainage is performed through the stomach, to avoid potential food impaction, which could result in stent dysfunction.
对于远端恶性胆道梗阻(DMBO)患者,内镜逆行胰胆管造影(ERCP)是缓解黄疸的金标准。当 ERCP 失败时,使用电切吻合金属支架(EC-LAMS)进行胆道引流是目前一种成熟的方法。在姑息治疗中,内镜超声引导下胆囊引流(EUS-GBD)可能是一种简单有效的选择。我们进行了一项前瞻性研究,使用一种新的 EC-LAMS,主要目的是评估 EUS-GBD 作为 DMBO 姑息治疗的一线方法的临床成功率。
共前瞻性纳入 37 例接受 EUS-GBD 联合新 EC-LAMS 的连续患者。临床成功定义为 EC-LAMS 放置后 24 小时内胆红素水平下降>15%,14 天内下降>50%。
患者平均年龄为 73.5±10.8 岁;男性 17 例(45.9%)。所有患者均成功进行了 EC-LAMS 放置(100%),临床成功率为 100%。4 例患者(10.8%)发生不良事件,1 例出血,1 例食物嵌塞,2 例因疾病进展导致胆囊管阻塞。未观察到支架相关死亡。平均住院时间为 7.7±3.4 天。中位总生存期为 4 个月(95%置信区间 1-8)。
对于不能手术的低生存患者,新的 EC-LAMS 引导的 EUS-GBD 是姑息性内镜胆道引流的有效选择,作为恶性黄疸的第一步治疗方法。对于较小直径的 EC-LAMS,特别是通过胃进行引流时,应优先选择,以避免潜在的食物嵌塞,这可能导致支架功能障碍。